UCD research team adopt drug repurposing strategies to develop novel cardiovascular disease therapies that can potentially be fast tracked to the clinic. A new project that focuses on the repurposing of FDA approved epigenetic based therapies for the treatment of diseases associated with cardiac hypertrophy hasbeen awarded funding from Enterprise Ireland.
Cancer, asthma, kidney injuries and antibiotics are just some of the areas likely to benefit from €13.5 million in funding for new health research projects announced today by Minister for Health Leo Varadkar. A total of 36 projects are being supported by the Health Research Board (HRB) over the next three to five years. Dr Paddy Mallon, Associate Dean for Research and Innovation, SMMS was among those invited to present details about a project which has been funded.
October 29th 2014 is World Psoriasis Day, a global event that aims to give an international voice to the 125 million people with psoriasis/psoriatic arthritis. Research led by Conway Fellow, Professor Oliver FitzGerald in St Vincent’s University Hospital shows that a delay of more than 6 months from initial symptoms to a diagnosis of psoriatic arthritis leads to poorer outcomes for patients.
Systems Biology Ireland and the European Molecular Biology Laboratory Sign Memorandum of Understanding
Professor Iain Mattaj, Director General of the European Molecular Biology Laboratory (EMBL) and Professor Walter Kolch, Director, Systems Biology Ireland (SBI) have signed a Memorandum of Understanding (MoU) with the objective of enhancing cooperation between the two institutes. This is the first MoU agreement signed between EMBL and an Irish Institution.
Launch partners include clinicians and researchers affiliated with University College Dublin, Boston Children’s Hospital, Queensland Institute of Medical Research (Australia) and Saitama Medical University (Japan). Those at dozens of institutions worldwide using NextCODE’s solutions and database infrastructure are also immediately able to take their studies and collaborations into the Exchange.
Med Day 2014 will take place on Friday October 17th and will benefit more Irish charities than ever before. CRY (Cardiac Risk in the Young), Cystic Fibrosis Ireland, The Irish Hospice Foundation, Helium, Bone Marrow for Leukaemia Trust, Laura Lynn House, St. Vincents Foundation and The Mater Foundation have all been selected for this year's event.
Are you a clinician with an innovative idea that could address an unmet patient need? Cleveland Clinic & Enterprise Ireland would like to recognise the importance of clinical innovation in Ireland by presenting the “Clinical Innovation Award”. This award will provide a grant of €15,000 and the opportunity to work with Cleveland Clinic & Enterprise Ireland to develop the commercial potential of your innovative idea from Ireland.
A ground-breaking study into a simple blood test that could help predict and prevent heart failure has been awarded the most prestigious research prize by the Royal College of General Practitioners (RCGP).